{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:57:31Z","timestamp":1794020251861,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atrophy of white and grey matter volumes occurs early in the brains of people with multiple sclerosis (pwMS) and has great clinical relevance. In clinical trials, brain atrophy can be quantified by magnetic resonance imaging (MRI) with automated software tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we analyze volumes of various brain regions with the software \u201cmd brain\u201d based on routine MRI scans of 53 pwMS in a real-world setting. We compare brain volumes of pwMS with an EDSS\u2009\u2265\u20093.5 and a disease duration\u2009\u2265\u200910\u00a0years to the brain volumes of pwMS with an EDSS\u2009&lt;\u20093.5 and a disease duration\u2009&lt;\u200910\u00a0years as well as with or without immunotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>pwMS with an EDSS\u2009\u2265\u20093.5 and a disease duration\u2009\u2265\u200910\u00a0years had significantly lower volumes of the total brain, the grey matter and of the frontal, temporal, parietal and occipital lobe regions as compared to pwMS with an EDSS\u2009&lt;\u20093.5 and a disease duration\u2009&lt;\u200910\u00a0years. Regional brain volumes were significantly lower in pwMS without immunotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study showed that higher EDSS, longer disease duration and absence of immunotherapy was associated with lower volumes in a number of brain regions. Further real-world studies may include larger patient cohorts in longitudinal analyses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-024-00339-y","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:01:56Z","timestamp":1723078916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2471-8222","authenticated-orcid":false,"given":"Caroline","family":"Reinhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Angstwurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Freudenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf A.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"1","key":"339_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson, R., & Giovannoni, G. (2019). Multiple sclerosis\u2014A review. European Journal of Neurology, 26(1), 27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"European Journal of Neurology"},{"issue":"4","key":"339_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1212\/WNL.0000000000003542","volume":"88","author":"MA Rocca","year":"2017","unstructured":"Rocca, M. A., Battaglini, M., Benedict, R. H., De Stefano, N., Geurts, J. J., Henry, R. G., Horsfield, M. A., Jenkinson, M., Pagani, E., & Filippi, M. (2017). Brain MRI atrophy quantification in MS: From methods to clinical application. Neurology, 88(4), 403\u2013413. https:\/\/doi.org\/10.1212\/WNL.0000000000003542","journal-title":"Neurology"},{"issue":"Pt 2","key":"339_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/brain\/awf025","volume":"125","author":"DT Chard","year":"2002","unstructured":"Chard, D. T., Griffin, C. M., Parker, G. J., Kapoor, R., Thompson, A. J., & Miller, D. H. (2002). Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain, 125(Pt 2), 327\u2013337. https:\/\/doi.org\/10.1093\/brain\/awf025","journal-title":"Brain"},{"issue":"10","key":"339_CR4","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1177\/1352458515616701","volume":"22","author":"L Kappos","year":"2016","unstructured":"Kappos, L., De Stefano, N., Freedman, M. S., Cree, B. A., Radue, E. W., Sprenger, T., Sormani, M. P., Smith, T., Haring, D. A., Piani Meier, D., & Tomic, D. (2016). Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019 (NEDA-4) in relapsing-remitting multiple sclerosis. Multiple Sclerosis, 22(10), 1297\u20131305. https:\/\/doi.org\/10.1177\/1352458515616701","journal-title":"Multiple Sclerosis"},{"issue":"2","key":"339_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40263-014-0140-z","volume":"28","author":"N De Stefano","year":"2014","unstructured":"De Stefano, N., Airas, L., Grigoriadis, N., Mattle, H. P., O\u2019Riordan, J., Oreja-Guevara, C., Sellebjerg, F., Stankoff, B., Walczak, A., Wiendl, H., & Kieseier, B. C. (2014). Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs, 28(2), 147\u2013156. https:\/\/doi.org\/10.1007\/s40263-014-0140-z","journal-title":"CNS Drugs"},{"issue":"3","key":"339_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ana.21436","volume":"64","author":"E Fisher","year":"2008","unstructured":"Fisher, E., Lee, J. C., Nakamura, K., & Rudick, R. A. (2008). Gray matter atrophy in multiple sclerosis: A longitudinal study. Annals of Neurology, 64(3), 255\u2013265. https:\/\/doi.org\/10.1002\/ana.21436","journal-title":"Annals of Neurology"},{"issue":"3","key":"339_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/aian.AIAN_159_19","volume":"22","author":"L Pandit","year":"2019","unstructured":"Pandit, L. (2019). No evidence of disease activity (NEDA) in multiple sclerosis\u2014Shifting the goal posts. Annals of Indian Academy of Neurology, 22(3), 261\u2013263. https:\/\/doi.org\/10.4103\/aian.AIAN_159_19","journal-title":"Annals of Indian Academy of Neurology"},{"key":"339_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200032","author":"D Rotstein","year":"2022","unstructured":"Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., Saab, G., & Shah, P. (2022). Association of NEDA-4 with no long-term disability progression in multiple sclerosis and comparison with NEDA-3: A systematic review and meta-analysis. Neurology Neuroimmunology & Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000200032","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"issue":"Suppl 1","key":"339_CR9","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1111\/j.1552-6569.2007.00130.x","volume":"17","author":"N De Stefano","year":"2007","unstructured":"De Stefano, N., Battaglini, M., & Smith, S. M. (2007). Measuring brain atrophy in multiple sclerosis. Journal of Neuroimaging, 17(Suppl 1), 10S-15S. https:\/\/doi.org\/10.1111\/j.1552-6569.2007.00130.x","journal-title":"Journal of Neuroimaging"},{"issue":"6","key":"339_CR10","doi-asserted-by":"publisher","first-page":"fcad271","DOI":"10.1093\/braincomms\/fcad271","volume":"5","author":"V Purrer","year":"2023","unstructured":"Purrer, V., Pohl, E., Lueckel, J. M., Borger, V., Sauer, M., Radbruch, A., Wullner, U., & Schmeel, F. C. (2023). Artificial-intelligence-based MRI brain volumetry in patients with essential tremor and tremor-dominant Parkinson\u2019s disease. Brain Communications, 5(6), fcad271. https:\/\/doi.org\/10.1093\/braincomms\/fcad271","journal-title":"Brain Communications"},{"issue":"Pt 3","key":"339_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/brain\/120.3.393","volume":"120","author":"B Ferguson","year":"1997","unstructured":"Ferguson, B., Matyszak, M. K., Esiri, M. M., & Perry, V. H. (1997). Axonal damage in acute multiple sclerosis lesions. Brain, 120(Pt 3), 393\u2013399. https:\/\/doi.org\/10.1093\/brain\/120.3.393","journal-title":"Brain"},{"issue":"4","key":"339_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2010.01.002","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin, V., Vogt, J., Radbruch, H., Nitsch, R., & Zipp, F. (2010). Multiple sclerosis\u2014Candidate mechanisms underlying CNS atrophy. Trends in Neurosciences, 33(4), 202\u2013210. https:\/\/doi.org\/10.1016\/j.tins.2010.01.002","journal-title":"Trends in Neurosciences"},{"issue":"9","key":"339_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00415-006-0503-6","volume":"254","author":"M Calabrese","year":"2007","unstructured":"Calabrese, M., Atzori, M., Bernardi, V., Morra, A., Romualdi, C., Rinaldi, L., McAuliffe, M. J., Barachino, L., Perini, P., Fischl, B., Battistin, L., & Gallo, P. (2007). Cortical atrophy is relevant in multiple sclerosis at clinical onset. Journal of Neurology, 254(9), 1212\u20131220. https:\/\/doi.org\/10.1007\/s00415-006-0503-6","journal-title":"Journal of Neurology"},{"issue":"2","key":"339_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0022-510x(00)00259-8","volume":"174","author":"A Paolillo","year":"2000","unstructured":"Paolillo, A., Pozzilli, C., Gasperini, C., Giugni, E., Mainero, C., Giuliani, S., Tomassini, V., Millefiorini, E., & Bastianello, S. (2000). Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with \u2018black holes\u2019, disease duration and clinical disability. Journal of the Neurological Sciences, 174(2), 85\u201391. https:\/\/doi.org\/10.1016\/s0022-510x(00)00259-8","journal-title":"Journal of the Neurological Sciences"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2377-11-153","volume":"11","author":"HE Hulst","year":"2011","unstructured":"Hulst, H. E., & Geurts, J. J. (2011). Gray matter imaging in multiple sclerosis: What have we learned? BMC Neurology, 11, 153. https:\/\/doi.org\/10.1186\/1471-2377-11-153","journal-title":"BMC Neurology"},{"issue":"2","key":"339_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi, A., Prados, F., Brownlee, W. J., Altmann, D. R., Tur, C., Cardoso, M. J., De Angelis, F., van de Pavert, S. H., Cawley, N., De Stefano, N., Stromillo, M. L., Battaglini, M., Ruggieri, S., Gasperini, C., Filippi, M., Rocca, M. A., Rovira, A., Sastre-Garriga, J., Vrenken, H., & Group, M. S. (2018). Deep gray matter volume loss drives disability worsening in multiple sclerosis. Annals of Neurology, 83(2), 210\u2013222. https:\/\/doi.org\/10.1002\/ana.25145","journal-title":"Annals of Neurology"},{"key":"339_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.64.8.1157","volume":"64","author":"MP Amato","year":"2007","unstructured":"Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Battaglini, M., Bartolozzi, M. L., Stromillo, M. L., Guidi, L., Siracusa, G., Sorbi, S., & Federico, A. (2007). Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Archives of neurology., 64, 1157\u20131161. https:\/\/doi.org\/10.1001\/archneur.64.8.1157","journal-title":"Archives of neurology."},{"issue":"3","key":"339_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.21423","volume":"64","author":"LK Fisniku","year":"2008","unstructured":"Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008). Gray matter atrophy is related to long-term disability in multiple sclerosis. Annals of Neurology, 64(3), 247\u2013254. https:\/\/doi.org\/10.1002\/ana.21423","journal-title":"Annals of Neurology"},{"issue":"2","key":"339_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10072-018-3617-6","volume":"40","author":"GM Hadjigeorgiou","year":"2019","unstructured":"Hadjigeorgiou, G. M., Kountra, P. M., Koutsis, G., Tsimourtou, V., Siokas, V., Dardioti, M., Rikos, D., Marogianni, C., Aloizou, A. M., Karadima, G., Ralli, S., Grigoriadis, N., Bogdanos, D., Panas, M., & Dardiotis, E. (2019). Replication study of GWAS risk loci in Greek multiple sclerosis patients. Neurological Sciences, 40(2), 253\u2013260. https:\/\/doi.org\/10.1007\/s10072-018-3617-6","journal-title":"Neurological Sciences"},{"issue":"1","key":"339_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13317-018-0109-x","volume":"9","author":"GK Vasileiadis","year":"2018","unstructured":"Vasileiadis, G. K., Dardiotis, E., Mavropoulos, A., Tsouris, Z., Tsimourtou, V., Bogdanos, D. P., Sakkas, L. I., & Hadjigeorgiou, G. M. (2018). Regulatory B and T lymphocytes in multiple sclerosis: Friends or foes? Autoimmunity Highlights, 9(1), 9. https:\/\/doi.org\/10.1007\/s13317-018-0109-x","journal-title":"Autoimmunity Highlights"},{"issue":"5","key":"339_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ana.25463","volume":"85","author":"BAC Cree","year":"2019","unstructured":"Cree, B. A. C., Hollenbach, J. A., Bove, R., Kirkish, G., Sacco, S., Caverzasi, E., Bischof, A., Gundel, T., Zhu, A. H., Papinutto, N., Stern, W. A., Bevan, C., Romeo, A., Goodin, D. S., Gelfand, J. M., Graves, J., Green, A. J., Wilson, M. R., & Hauser, S. L. (2019). Silent progression in disease activity-free relapsing multiple sclerosis. Annals of Neurology, 85(5), 653\u2013666. https:\/\/doi.org\/10.1002\/ana.25463","journal-title":"Annals of Neurology"},{"issue":"5","key":"339_CR22","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1007\/s00330-021-08405-8","volume":"32","author":"IA Lie","year":"2022","unstructured":"Lie, I. A., Kerklingh, E., Wesnes, K., van Nederpelt, D. R., Brouwer, I., Torkildsen, O., Myhr, K. M., Barkhof, F., Bo, L., & Vrenken, H. (2022). The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis. European Radiology, 32(5), 3576\u20133587. https:\/\/doi.org\/10.1007\/s00330-021-08405-8","journal-title":"European Radiology"},{"issue":"3","key":"339_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41582-020-0314-x","volume":"16","author":"J Sastre-Garriga","year":"2020","unstructured":"Sastre-Garriga, J., Pareto, D., Battaglini, M., Rocca, M. A., Ciccarelli, O., Enzinger, C., Wuerfel, J., Sormani, M. P., Barkhof, F., Yousry, T. A., De Stefano, N., Tintore, M., Filippi, M., Gasperini, C., Kappos, L., Rio, J., Frederiksen, J., Palace, J., Vrenken, H., & Group, M. S. (2020). MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nature Reviews Neurology, 16(3), 171\u2013182. https:\/\/doi.org\/10.1038\/s41582-020-0314-x","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"339_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nic.2008.06.007","volume":"18","author":"A Giorgio","year":"2008","unstructured":"Giorgio, A., Battaglini, M., Smith, S. M., & De Stefano, N. (2008). Brain atrophy assessment in multiple sclerosis: Importance and limitations. Neuroimaging Clinics of North America, 18(4), 675\u2013686. https:\/\/doi.org\/10.1016\/j.nic.2008.06.007","journal-title":"Neuroimaging Clinics of North America"},{"issue":"Suppl 1","key":"339_CR25","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0022-510X(09)71297-3","volume":"287","author":"F Zipp","year":"2009","unstructured":"Zipp, F. (2009). A new window in multiple sclerosis pathology: Non-conventional quantitative magnetic resonance imaging outcomes. Journal of the Neurological Sciences, 287(Suppl 1), S24-29. https:\/\/doi.org\/10.1016\/S0022-510X(09)71297-3","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"339_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1212\/WNL.0b013e3181b2a706","volume":"73","author":"R Zivadinov","year":"2009","unstructured":"Zivadinov, R., Weinstock-Guttman, B., Hashmi, K., Abdelrahman, N., Stosic, M., Dwyer, M., Hussein, S., Durfee, J., & Ramanathan, M. (2009). Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology, 73(7), 504\u2013510. https:\/\/doi.org\/10.1212\/WNL.0b013e3181b2a706","journal-title":"Neurology"},{"issue":"1","key":"339_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/ene.15579","volume":"30","author":"R Cortese","year":"2023","unstructured":"Cortese, R., Battaglini, M., Sormani, M. P., Luchetti, L., Gentile, G., Inderyas, M., Alexandri, N., & De Stefano, N. (2023). Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets. European Journal of Neurology, 30(1), 179\u2013186. https:\/\/doi.org\/10.1111\/ene.15579","journal-title":"European Journal of Neurology"},{"issue":"2","key":"339_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","volume":"5","author":"RA Bermel","year":"2006","unstructured":"Bermel, R. A., & Bakshi, R. (2006). The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurology, 5(2), 158\u2013170. https:\/\/doi.org\/10.1016\/S1474-4422(06)70349-0","journal-title":"Lancet Neurology"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-024-00339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-024-00339-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-024-00339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:02:06Z","timestamp":1723078926000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-024-00339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1186\/s42466-024-00339-y","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study as approved by the Ethics Committee, University of Regensburg, Bavaria, Germany.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RL is Editorial board member of Neurological Research and Practice.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}